KMB
NASDAQ · Consumer Defensive · Household & Personal Products · US
Research · Sep 3, 2026
[KMB] Kimberly-Clark Thesis 2026: Powering Care Strategy Launches With Kenview Acquisition
Kimberly-Clark FY25 revenue $17.22B (-14% reported on portfolio simplification + FX + Personal Care divestiture); op income $2.49B (-22%); NI $2.02B; EPS $6.07 (vs $7.55). Underlying volume + mix grew 8 consecutive quarters. Industry-leading productivity (Q4 strongest). Power and Care strategic plan year 2. Kenview acquisition. FY26: organic sales in line/ahead of category, ~6% productivity, mid-to-high single OI growth, adj EPS in line FY25 cc.
Research · Apr 27, 2026
PG Q3 Beats: Sales +7%, Tariff Headwind Cleared
Procter & Gamble's fiscal Q3 results met Wall Street expectations, clearing tariff and margin fears that drove the March selloff. The stock is positioned for a 1-2% tactical move as the downside case is removed, but muted peer response signals limited sector read-through. The trade is a 30-day long in PG, fading if Q4 fails to show margin expansion or if broader market volatility exceeds 5%.